Search

everythinglearnresearchcommunity

for

Search:↓

Intramuscular injections improved hair density more than intradermal injections for treating hair loss.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

New drug delivery systems improve treatment effectiveness and patient experience.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Testosterone therapy can improve hormone levels and quality of life in men with morphine-induced hormone issues.

The method effectively delivers vaccines through the skin without needles.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Medroxyprogesterone acetate injections are more effective than topical ointment in treating excessive hair growth in women.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Testosterone increases muscle mass regardless of DHT conversion blocking.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

The three-layer microneedle system effectively delivers minoxidil into the skin, showing potential as a safe and efficient treatment for hair loss.

Sublingual minoxidil safely increases hair growth in transgender people on testosterone therapy.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Sublingual minoxidil significantly improves hair growth in transgender individuals on testosterone therapy.

The multi-injection plate is a less painful and more efficient method for treating patchy hair loss.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

Intradermal dutasteride effectively and safely improves hair growth in early-stage androgenetic alopecia.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.